00000nam 2200000za 4500 9.823547 CaOODSP 20221107143925 cr ||||||||||| 160902s2007 onc |o f|0| 0 eng d CaOODSP eng n-cn--- H14-183/2007E-PDF Horizontal evaluation of the Genomics Research and Development Initiative [electronic resource] : final report. [Ottawa] : Health Canada, 2007. [311] p. in various pagings Issued also in French under title: Évaluation horizontale de l'Initiative de recherche et de développement en génomique : rapport final. "December 20, 2007." "Approved by Departmental Executive Committee -Finance, Evaluation and Accountability (DEC-FEA) Health Canada." Includes bibliographical references. In March 1998, the National Biotechnology Advisory Committee (NBAC) released a report recommending ways to position Canada as a leading global player in biotechnology by the year 2005. During the same period, the National Research Council (NRC) and the Medical Research Council (now the Canadian Institutes of Health Research) held discussions with stakeholders as part of the Canadian Biotechnology consultations. Genome research was clearly identified as an important priority for Canadian biotechnology research and development (R&D). The NBAC recommended that a top priority be placed on several actions, including political championship and increased funding to Canada's genome program. The February 1999 Budget provided $55 million in funding for genomics R&D in six departments and agencies under the Canadian Biotechnology Strategy (CBS). ... gccst Genomics gccst Program assessment Canada. Health Canada. Évaluation horizontale de l'Initiative de recherche et de développement en génomique (CaOODSP)9.823549 PDF 849 KB https://publications.gc.ca/collections/collection_2016/sc-hc/H14-183-2007-eng.pdf